Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients

Last updated: March 8, 2016
Sponsor: Yao Liao
Overall Status: Trial Status Unknown

Phase

4

Condition

Allergy

Lung Cancer

Rash

Treatment

N/A

Clinical Study ID

NCT02495064
MianyangCH
  • Ages > 12
  • All Genders

Study Summary

Radiation dermatitis is an acute effect of radiation therapy,Especially in the neck skin of head and neck squamous cell carcinomas' patients.The investigators wanted to confirm the benefit of mometasone furoate (MF) in preventing acute radiation reactions, as shown in a previous study.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • pathological diagnosis for head and neck squamous cell carcinomas and

  • going to have radiotherapy.

Exclusion

Exclusion Criteria:

  • pregnant,

  • lactating women,

  • infants,

  • elderly people with atrophy skin,

  • allergic constitution patients,

  • the corresponding parts of 5 radiotherapy skin ulceration or infection and

  • allergic patients to Mometasone Furoate Cream.

Study Design

Total Participants: 160
Study Start date:
January 01, 2015
Estimated Completion Date:
December 31, 2016

Study Description

A randomized,self-comparative controlled trial was undertaken comparing MF cream with no cream administered from the first day of treatment for 5-6 weeks to prevent radiation dermatitis of neck during radiation therapy to the head and neck squamous cell carcinomas' Patients.

One side of patients' neck will begin to use MF cream from the first day of radiation therapy, while the other side accept no preventive measures.

Connect with a study center

  • oncology department of Mian yang central Hosptial

    Mianyang, Sichuan 0816
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.